- +1 (818) 270 1953
- +52 (33) 3371 0033
- contact@stemlifeclinic.com
- Mon - Fri: 9:00 - 17:00
Menu
Characterized by progressive scarring that causes the lung to lose flexibility, and its function deteriorates over time.
It is a chronic disease that affects both lungs diffusely, characterized by a progressive scarring (fibrosis) that causes the lung to lose flexibility, and its function deteriorates over time.
The cause is unknown, but there are some potential risks for developing this disease, among which are the following:
The symptoms of pulmonary fibrosis can be very variable, from not producing any symptoms to producing exhaustion with any effort.
The most frequent are shortness of breath on exertion and coughing, which progress over years or months, and, in advanced stages, respiratory failure with the need for oxygen therapy.
Diagnosis is made by adequate clinical questioning, chest radiography and high-resolution computed tomography.
Lung tissue biopsy may be required when the alterations seen on computed tomography do not allow a definitive diagnosis of the disease. This biopsy can be performed by bronchoscopy or surgery.
The 6-minute walk test is used to assess the impact of the disease on exercise capacity. These measurements make it possible to assess the severity of the disease, its evolution over time and the response to treatment.
Among the complications of pulmonary fibrosis, the following can be mentioned:
MSC therapy is a safe and effective approach that can significantly improve survival and lung fibrosis
Intravenous infusion with MSCs can block the progression of lung damage and at the same time, decrease existing fibrotic lesions in lung tissue.
Stay Informed & Healthy
The #1 clinic for stem cell therapy in Mexico.
Av. Pablo Neruda #2828, Piso 3/C, Providencia 4a. Secc, 44630, Guadalajara, Jal.